

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.14428547 |
| 2 | central nervous system myelination (GO:0022010) | 8.14428547 |
| 3 | hemidesmosome assembly (GO:0031581) | 5.45536951 |
| 4 | fatty acid elongation (GO:0030497) | 5.37767771 |
| 5 | ensheathment of neurons (GO:0007272) | 4.88773229 |
| 6 | axon ensheathment (GO:0008366) | 4.88773229 |
| 7 | myelination (GO:0042552) | 4.86496023 |
| 8 | desmosome organization (GO:0002934) | 4.77630989 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.63381939 |
| 10 | myelin maintenance (GO:0043217) | 4.36895836 |
| 11 | neuronal action potential propagation (GO:0019227) | 4.02017530 |
| 12 | negative regulation of neurotransmitter transport (GO:0051589) | 3.99944158 |
| 13 | establishment of mitochondrion localization (GO:0051654) | 3.96819252 |
| 14 | neurofilament cytoskeleton organization (GO:0060052) | 3.91688490 |
| 15 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.91587186 |
| 16 | synaptic vesicle maturation (GO:0016188) | 3.74975926 |
| 17 | cell-substrate junction assembly (GO:0007044) | 3.74710755 |
| 18 | L-amino acid import (GO:0043092) | 3.72130256 |
| 19 | response to methylmercury (GO:0051597) | 3.66056100 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 3.47762847 |
| 21 | apical protein localization (GO:0045176) | 3.41158077 |
| 22 | adult walking behavior (GO:0007628) | 3.31679277 |
| 23 | hypotonic response (GO:0006971) | 3.30486130 |
| 24 | iron ion import (GO:0097286) | 3.29163440 |
| 25 | glycine transport (GO:0015816) | 3.24468129 |
| 26 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.23459969 |
| 27 | synaptic vesicle exocytosis (GO:0016079) | 3.22585899 |
| 28 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.19329845 |
| 29 | transmission of nerve impulse (GO:0019226) | 3.17204590 |
| 30 | asymmetric protein localization (GO:0008105) | 3.17005195 |
| 31 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.16366899 |
| 32 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.16031067 |
| 33 | mesodermal cell differentiation (GO:0048333) | 3.15790766 |
| 34 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.14364656 |
| 35 | positive regulation of receptor recycling (GO:0001921) | 3.10233701 |
| 36 | negative regulation of protein localization to cell surface (GO:2000009) | 3.09654802 |
| 37 | axon development (GO:0061564) | 3.07185061 |
| 38 | presynaptic membrane organization (GO:0097090) | 3.06282686 |
| 39 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.05947065 |
| 40 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.05947065 |
| 41 | cellular potassium ion homeostasis (GO:0030007) | 3.05788266 |
| 42 | beta-amyloid metabolic process (GO:0050435) | 3.04067572 |
| 43 | oligodendrocyte differentiation (GO:0048709) | 3.01620350 |
| 44 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.01619597 |
| 45 | mating behavior (GO:0007617) | 2.99461735 |
| 46 | amyloid precursor protein metabolic process (GO:0042982) | 2.97349787 |
| 47 | glutamate secretion (GO:0014047) | 2.96838116 |
| 48 | regulation of water loss via skin (GO:0033561) | 2.95001976 |
| 49 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.94207839 |
| 50 | eye photoreceptor cell differentiation (GO:0001754) | 2.91753373 |
| 51 | photoreceptor cell differentiation (GO:0046530) | 2.91753373 |
| 52 | establishment of skin barrier (GO:0061436) | 2.91153090 |
| 53 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.91083480 |
| 54 | actin-myosin filament sliding (GO:0033275) | 2.90840424 |
| 55 | muscle filament sliding (GO:0030049) | 2.90840424 |
| 56 | cholesterol biosynthetic process (GO:0006695) | 2.90588993 |
| 57 | COPI coating of Golgi vesicle (GO:0048205) | 2.90326321 |
| 58 | Golgi transport vesicle coating (GO:0048200) | 2.90326321 |
| 59 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.89032358 |
| 60 | potassium ion homeostasis (GO:0055075) | 2.88518996 |
| 61 | import into cell (GO:0098657) | 2.88110921 |
| 62 | regulation of collateral sprouting (GO:0048670) | 2.88054652 |
| 63 | glycerophospholipid catabolic process (GO:0046475) | 2.88024392 |
| 64 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.87794788 |
| 65 | regulation of platelet aggregation (GO:0090330) | 2.87299067 |
| 66 | substantia nigra development (GO:0021762) | 2.86230951 |
| 67 | amino acid import (GO:0043090) | 2.85683496 |
| 68 | regulation of early endosome to late endosome transport (GO:2000641) | 2.84748269 |
| 69 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.83516840 |
| 70 | presynaptic membrane assembly (GO:0097105) | 2.82284723 |
| 71 | nerve growth factor signaling pathway (GO:0038180) | 2.80585993 |
| 72 | neuromuscular process controlling posture (GO:0050884) | 2.80291918 |
| 73 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.80234771 |
| 74 | potassium ion import (GO:0010107) | 2.79278457 |
| 75 | detection of temperature stimulus (GO:0016048) | 2.79203691 |
| 76 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.78957251 |
| 77 | protein targeting to plasma membrane (GO:0072661) | 2.76848230 |
| 78 | neuronal ion channel clustering (GO:0045161) | 2.74978068 |
| 79 | negative regulation of axonogenesis (GO:0050771) | 2.74584847 |
| 80 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.70909120 |
| 81 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.70319278 |
| 82 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.69733890 |
| 83 | astrocyte development (GO:0014002) | 2.68441309 |
| 84 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.67729172 |
| 85 | neuron recognition (GO:0008038) | 2.67645486 |
| 86 | regulation of protein localization to cell surface (GO:2000008) | 2.67107446 |
| 87 | protein localization to endosome (GO:0036010) | 2.67095165 |
| 88 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.66872397 |
| 89 | sodium ion export (GO:0071436) | 2.66620081 |
| 90 | platelet degranulation (GO:0002576) | 2.65129062 |
| 91 | positive regulation of potassium ion transport (GO:0043268) | 2.64712082 |
| 92 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.64468695 |
| 93 | establishment of protein localization to plasma membrane (GO:0090002) | 2.64452146 |
| 94 | neurotransmitter uptake (GO:0001504) | 2.63025719 |
| 95 | membrane raft organization (GO:0031579) | 2.62025296 |
| 96 | Golgi to plasma membrane transport (GO:0006893) | 2.62020098 |
| 97 | relaxation of muscle (GO:0090075) | 2.61092917 |
| 98 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.60817770 |
| 99 | plasma membrane repair (GO:0001778) | 2.59777830 |
| 100 | creatine metabolic process (GO:0006600) | 2.59712543 |
| 101 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.59660502 |
| 102 | organelle transport along microtubule (GO:0072384) | 2.59612239 |
| 103 | negative regulation of inclusion body assembly (GO:0090084) | 2.59489141 |
| 104 | epithelial cell-cell adhesion (GO:0090136) | 2.59088507 |
| 105 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.58846326 |
| 106 | magnesium ion transport (GO:0015693) | 2.58011823 |
| 107 | actin-mediated cell contraction (GO:0070252) | 2.57950041 |
| 108 | Golgi to plasma membrane protein transport (GO:0043001) | 2.57759353 |
| 109 | sterol biosynthetic process (GO:0016126) | 2.57338629 |
| 110 | response to lipoprotein particle (GO:0055094) | 2.56789900 |
| 111 | extracellular fibril organization (GO:0043206) | 2.56786384 |
| 112 | regulation of synaptic vesicle transport (GO:1902803) | 2.56679195 |
| 113 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.55813259 |
| 114 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.54944457 |
| 115 | adenosine receptor signaling pathway (GO:0001973) | 2.52965106 |
| 116 | protein palmitoylation (GO:0018345) | 2.52662820 |
| 117 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.52179053 |
| 118 | gamma-aminobutyric acid transport (GO:0015812) | 2.51425769 |
| 119 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.49075593 |
| 120 | peripheral nervous system axon ensheathment (GO:0032292) | 2.48793866 |
| 121 | myelination in peripheral nervous system (GO:0022011) | 2.48793866 |
| 122 | cell adhesion mediated by integrin (GO:0033627) | 2.48768215 |
| 123 | axon cargo transport (GO:0008088) | 2.48657075 |
| 124 | response to lead ion (GO:0010288) | 2.48490946 |
| 125 | adherens junction assembly (GO:0034333) | 2.47853360 |
| 126 | glycosylceramide metabolic process (GO:0006677) | 2.47852700 |
| 127 | neuron remodeling (GO:0016322) | 2.47373967 |
| 128 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.47181779 |
| 129 | skin morphogenesis (GO:0043589) | 2.47112882 |
| 130 | skeletal muscle contraction (GO:0003009) | 2.47078084 |
| 131 | regulation of lipoprotein metabolic process (GO:0050746) | 2.46732816 |
| 132 | adhesion of symbiont to host cell (GO:0044650) | 2.46310527 |
| 133 | virion attachment to host cell (GO:0019062) | 2.46310527 |
| 134 | thrombin receptor signaling pathway (GO:0070493) | 2.45247085 |
| 135 | barbed-end actin filament capping (GO:0051016) | 2.44818037 |
| 136 | vesicle transport along microtubule (GO:0047496) | 2.44639281 |
| 137 | dendrite morphogenesis (GO:0048813) | 2.44246659 |
| 138 | stress fiber assembly (GO:0043149) | 2.44121533 |
| 139 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.43955047 |
| 140 | regulation of receptor recycling (GO:0001919) | 2.43361077 |
| 141 | keratinocyte proliferation (GO:0043616) | 2.42544112 |
| 142 | actin filament-based movement (GO:0030048) | 2.42200051 |
| 143 | vocalization behavior (GO:0071625) | 2.41829514 |
| 144 | membrane tubulation (GO:0097320) | 2.41726762 |
| 145 | platelet aggregation (GO:0070527) | 2.40714946 |
| 146 | enteric nervous system development (GO:0048484) | 2.40225800 |
| 147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.39531818 |
| 148 | adult locomotory behavior (GO:0008344) | 2.39254371 |
| 149 | cell-substrate adherens junction assembly (GO:0007045) | 2.38748784 |
| 150 | focal adhesion assembly (GO:0048041) | 2.38748784 |
| 151 | axonal fasciculation (GO:0007413) | 2.38396637 |
| 152 | neurotransmitter transport (GO:0006836) | 2.37477146 |
| 153 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.36348618 |
| 154 | mitochondrion transport along microtubule (GO:0047497) | 2.35917108 |
| 155 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.35917108 |
| 156 | sensory perception of smell (GO:0007608) | 2.35472029 |
| 157 | regulation of protein localization to plasma membrane (GO:1903076) | 2.34883731 |
| 158 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.32538304 |
| 159 | linoleic acid metabolic process (GO:0043651) | 2.31833602 |
| 160 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.31128099 |
| 161 | protein localization to plasma membrane (GO:0072659) | 2.30875420 |
| 162 | activation of protein kinase A activity (GO:0034199) | 2.30125064 |
| 163 | negative regulation of cell junction assembly (GO:1901889) | 2.29993911 |
| 164 | negative regulation of adherens junction organization (GO:1903392) | 2.29993911 |
| 165 | negative regulation of focal adhesion assembly (GO:0051895) | 2.29993911 |
| 166 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.29849738 |
| 167 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.28797454 |
| 168 | fibril organization (GO:0097435) | 2.27169526 |
| 169 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.26302734 |
| 170 | endocytic recycling (GO:0032456) | 2.24930642 |
| 171 | cell junction assembly (GO:0034329) | 2.22242247 |
| 172 | relaxation of smooth muscle (GO:0044557) | 2.21640900 |
| 173 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.21188966 |
| 174 | positive regulation of muscle hypertrophy (GO:0014742) | 2.21188966 |
| 175 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.20948173 |
| 176 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.20911184 |
| 177 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.19995824 |
| 178 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.18703252 |
| 179 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.18343184 |
| 180 | negative regulation of muscle contraction (GO:0045932) | 2.17816651 |
| 181 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.17139007 |
| 182 | striated muscle contraction (GO:0006941) | 2.16583120 |
| 183 | cerebellar granule cell differentiation (GO:0021707) | 2.16174845 |
| 184 | cell communication involved in cardiac conduction (GO:0086065) | 2.15960902 |
| 185 | response to parathyroid hormone (GO:0071107) | 2.15920204 |
| 186 | protein retention in ER lumen (GO:0006621) | 2.15706598 |
| 187 | regulation of ARF protein signal transduction (GO:0032012) | 2.15001766 |
| 188 | plasma membrane organization (GO:0007009) | 2.14594846 |
| 189 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.12564326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.75477385 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27408410 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.02598030 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76662413 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.73696001 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.64669517 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.61977610 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.54033249 |
| 9 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.51657121 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37474345 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34045964 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34037339 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34037339 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.28904938 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22423725 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18725515 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15256139 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.12115048 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.10380284 |
| 20 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.05920924 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05183614 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.02651581 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.99658063 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.97917558 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97596072 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.95915589 |
| 27 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95408418 |
| 28 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.95327636 |
| 29 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.95327636 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89643065 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86015210 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.84948169 |
| 33 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.84581793 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84001331 |
| 35 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.81258360 |
| 36 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.75537521 |
| 37 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75280647 |
| 38 | GATA1_19941826_ChIP-Seq_K562_Human | 1.71621344 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.70442634 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.70171347 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.65486906 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.64816738 |
| 43 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61958439 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.61693970 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58682928 |
| 46 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.55941272 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.54586593 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.52741374 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.52741374 |
| 50 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.52215793 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51556129 |
| 52 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.51056275 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.50303199 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49692683 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.46669514 |
| 56 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.46053897 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45607039 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45325448 |
| 59 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.44532739 |
| 60 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43047513 |
| 61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41769525 |
| 62 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38996187 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38128212 |
| 64 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.38064144 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37584840 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36907983 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.36228283 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.35685990 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33780731 |
| 70 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33115642 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.33102571 |
| 72 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.32886190 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32751805 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31751463 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.31629742 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31121761 |
| 77 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30098833 |
| 78 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29704884 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.29560035 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29384539 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28703308 |
| 82 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27080785 |
| 83 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.27054587 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26974063 |
| 85 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24855116 |
| 86 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.24382392 |
| 87 | CJUN_26792858_Chip-Seq_BT549_Human | 1.23163852 |
| 88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22915572 |
| 89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20928569 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20761169 |
| 91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20423452 |
| 92 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20236002 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20123756 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20050539 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19606919 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.18969097 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.18969097 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18824054 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18788968 |
| 100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.16477847 |
| 101 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15880626 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15149098 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15010736 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14897956 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14564993 |
| 106 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14448645 |
| 107 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13357736 |
| 108 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12967674 |
| 109 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12740464 |
| 110 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11367278 |
| 111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11241741 |
| 112 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.11166156 |
| 113 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10743196 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10735264 |
| 115 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09715721 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09439131 |
| 117 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09039608 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09031826 |
| 119 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.08417769 |
| 120 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08240704 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07868100 |
| 122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06845158 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.06184463 |
| 124 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05764348 |
| 125 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05609105 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04181878 |
| 127 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03882617 |
| 128 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03750015 |
| 129 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03535233 |
| 130 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03216838 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02946499 |
| 132 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02682439 |
| 133 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.02107355 |
| 134 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00765110 |
| 135 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99908943 |
| 136 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98219457 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.97389824 |
| 138 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96881986 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96439796 |
| 140 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95750059 |
| 141 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95183187 |
| 142 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94774238 |
| 143 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94320363 |
| 144 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93834803 |
| 145 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92982927 |
| 146 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92617579 |
| 147 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.91595159 |
| 148 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90919820 |
| 149 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90585786 |
| 150 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.90545201 |
| 151 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89274118 |
| 152 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89084283 |
| 153 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.89073310 |
| 154 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88461320 |
| 155 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.87702719 |
| 156 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87368525 |
| 157 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86785278 |
| 158 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86615219 |
| 159 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86508206 |
| 160 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.86496979 |
| 161 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86447148 |
| 162 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86023830 |
| 163 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.85756986 |
| 164 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85000333 |
| 165 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84780917 |
| 166 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84187411 |
| 167 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84155040 |
| 168 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83589809 |
| 169 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.83121652 |
| 170 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82962501 |
| 171 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82947293 |
| 172 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82934388 |
| 173 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82776881 |
| 174 | KDM2B_26808549_Chip-Seq_K562_Human | 0.82532013 |
| 175 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.82382570 |
| 176 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.82332357 |
| 177 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81649108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.30833582 |
| 2 | MP0000920_abnormal_myelination | 3.99840762 |
| 3 | MP0004270_analgesia | 3.84096486 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.69368487 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.51023270 |
| 6 | MP0003566_abnormal_cell_adhesion | 3.27476791 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.18442816 |
| 8 | MP0003329_amyloid_beta_deposits | 3.05673160 |
| 9 | MP0002272_abnormal_nervous_system | 2.82377870 |
| 10 | MP0005275_abnormal_skin_tensile | 2.81506734 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 2.81438177 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.71429847 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.67682890 |
| 14 | MP0002064_seizures | 2.64459933 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.64080804 |
| 16 | MP0009046_muscle_twitch | 2.60544465 |
| 17 | MP0001486_abnormal_startle_reflex | 2.50992500 |
| 18 | MP0003690_abnormal_glial_cell | 2.44973401 |
| 19 | MP0000749_muscle_degeneration | 2.41133685 |
| 20 | MP0004272_abnormal_basement_membrane | 2.40496732 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.39185592 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 2.38331990 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.37153547 |
| 24 | MP0009745_abnormal_behavioral_response | 2.30964733 |
| 25 | MP0004036_abnormal_muscle_relaxation | 2.25405217 |
| 26 | MP0001529_abnormal_vocalization | 2.14786241 |
| 27 | MP0004510_myositis | 2.12744612 |
| 28 | MP0001970_abnormal_pain_threshold | 2.12636173 |
| 29 | MP0002736_abnormal_nociception_after | 2.09588794 |
| 30 | MP0005423_abnormal_somatic_nervous | 2.07938528 |
| 31 | MP0004885_abnormal_endolymph | 2.05343429 |
| 32 | MP0002733_abnormal_thermal_nociception | 2.04607409 |
| 33 | MP0003634_abnormal_glial_cell | 2.04578816 |
| 34 | MP0001905_abnormal_dopamine_level | 2.02140073 |
| 35 | MP0004147_increased_porphyrin_level | 2.00816779 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 2.00127246 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.99250976 |
| 38 | MP0004742_abnormal_vestibular_system | 1.98307850 |
| 39 | MP0004084_abnormal_cardiac_muscle | 1.93706859 |
| 40 | MP0003045_fibrosis | 1.93628553 |
| 41 | MP0005451_abnormal_body_composition | 1.93097631 |
| 42 | MP0004142_abnormal_muscle_tone | 1.92431034 |
| 43 | MP0003950_abnormal_plasma_membrane | 1.91847051 |
| 44 | MP0000778_abnormal_nervous_system | 1.86777063 |
| 45 | MP0003091_abnormal_cell_migration | 1.81502368 |
| 46 | MP0002572_abnormal_emotion/affect_behav | 1.80456741 |
| 47 | MP0008569_lethality_at_weaning | 1.77140724 |
| 48 | MP0002229_neurodegeneration | 1.74578452 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.74237616 |
| 50 | MP0002822_catalepsy | 1.73171675 |
| 51 | MP0001984_abnormal_olfaction | 1.71044181 |
| 52 | MP0001440_abnormal_grooming_behavior | 1.68655802 |
| 53 | MP0001958_emphysema | 1.64644606 |
| 54 | MP0001485_abnormal_pinna_reflex | 1.62732469 |
| 55 | MP0002060_abnormal_skin_morphology | 1.62272272 |
| 56 | MP0000604_amyloidosis | 1.62222861 |
| 57 | MP0005023_abnormal_wound_healing | 1.60885355 |
| 58 | MP0003633_abnormal_nervous_system | 1.59350372 |
| 59 | MP0004858_abnormal_nervous_system | 1.58923179 |
| 60 | MP0000955_abnormal_spinal_cord | 1.58814497 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.57765574 |
| 62 | MP0004233_abnormal_muscle_weight | 1.57645506 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.55682711 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.54687353 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.51881249 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.51768174 |
| 67 | MP0005171_absent_coat_pigmentation | 1.51079722 |
| 68 | MP0003631_nervous_system_phenotype | 1.51037949 |
| 69 | MP0004947_skin_inflammation | 1.50799073 |
| 70 | MP0003632_abnormal_nervous_system | 1.49249014 |
| 71 | MP0004087_abnormal_muscle_fiber | 1.47883399 |
| 72 | MP0002882_abnormal_neuron_morphology | 1.47830203 |
| 73 | MP0003879_abnormal_hair_cell | 1.45119886 |
| 74 | MP0005501_abnormal_skin_physiology | 1.44141868 |
| 75 | MP0008004_abnormal_stomach_pH | 1.43697460 |
| 76 | MP0004924_abnormal_behavior | 1.43195553 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.43195553 |
| 78 | MP0005409_darkened_coat_color | 1.42971772 |
| 79 | MP0005165_increased_susceptibility_to | 1.39205598 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 1.38475800 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.37981560 |
| 82 | MP0000759_abnormal_skeletal_muscle | 1.36428074 |
| 83 | MP0001299_abnormal_eye_distance/ | 1.36131288 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 1.35355294 |
| 85 | MP0002184_abnormal_innervation | 1.34039432 |
| 86 | MP0005620_abnormal_muscle_contractility | 1.33156018 |
| 87 | MP0002972_abnormal_cardiac_muscle | 1.30935433 |
| 88 | MP0004130_abnormal_muscle_cell | 1.30173336 |
| 89 | MP0004043_abnormal_pH_regulation | 1.28168230 |
| 90 | MP0005410_abnormal_fertilization | 1.27914982 |
| 91 | MP0005666_abnormal_adipose_tissue | 1.22004490 |
| 92 | MP0006138_congestive_heart_failure | 1.21648721 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 1.20361438 |
| 94 | MP0004811_abnormal_neuron_physiology | 1.20262293 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 1.19804667 |
| 96 | MP0002896_abnormal_bone_mineralization | 1.19195148 |
| 97 | MP0003828_pulmonary_edema | 1.18843037 |
| 98 | MP0010678_abnormal_skin_adnexa | 1.17815776 |
| 99 | MP0001216_abnormal_epidermal_layer | 1.16881582 |
| 100 | MP0000733_abnormal_muscle_development | 1.16568567 |
| 101 | MP0004484_altered_response_of | 1.15247940 |
| 102 | MP0005166_decreased_susceptibility_to | 1.12899368 |
| 103 | MP0005058_abnormal_lysosome_morphology | 1.11955389 |
| 104 | MP0002557_abnormal_social/conspecific_i | 1.11806237 |
| 105 | MP0001963_abnormal_hearing_physiology | 1.11026110 |
| 106 | MP0000462_abnormal_digestive_system | 1.10433171 |
| 107 | MP0002269_muscular_atrophy | 1.10033436 |
| 108 | MP0003136_yellow_coat_color | 1.09838697 |
| 109 | MP0010771_integument_phenotype | 1.09172844 |
| 110 | MP0000747_muscle_weakness | 1.08913855 |
| 111 | MP0000467_abnormal_esophagus_morphology | 1.06602396 |
| 112 | MP0005623_abnormal_meninges_morphology | 1.05783372 |
| 113 | MP0001879_abnormal_lymphatic_vessel | 1.05502261 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 1.03913074 |
| 115 | MP0000377_abnormal_hair_follicle | 1.03635365 |
| 116 | MP0005330_cardiomyopathy | 1.03444021 |
| 117 | MP0002752_abnormal_somatic_nervous | 1.01905620 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 1.01039383 |
| 119 | MP0001765_abnormal_ion_homeostasis | 1.00974788 |
| 120 | MP0005551_abnormal_eye_electrophysiolog | 0.97888377 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.96435886 |
| 122 | MP0001346_abnormal_lacrimal_gland | 0.94748416 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.94551168 |
| 124 | MP0005375_adipose_tissue_phenotype | 0.92626306 |
| 125 | MP0002106_abnormal_muscle_physiology | 0.92222927 |
| 126 | MP0001849_ear_inflammation | 0.91383796 |
| 127 | MP0003941_abnormal_skin_development | 0.90611744 |
| 128 | MP0001348_abnormal_lacrimal_gland | 0.90501720 |
| 129 | MP0010368_abnormal_lymphatic_system | 0.88187141 |
| 130 | MP0005646_abnormal_pituitary_gland | 0.88095126 |
| 131 | MP0002166_altered_tumor_susceptibility | 0.87751884 |
| 132 | MP0008260_abnormal_autophagy | 0.87287787 |
| 133 | MP0001502_abnormal_circadian_rhythm | 0.86008052 |
| 134 | MP0004134_abnormal_chest_morphology | 0.85007270 |
| 135 | MP0001661_extended_life_span | 0.84938680 |
| 136 | MP0001986_abnormal_taste_sensitivity | 0.82960249 |
| 137 | MP0001851_eye_inflammation | 0.81112754 |
| 138 | MP0000750_abnormal_muscle_regeneration | 0.80575762 |
| 139 | MP0002152_abnormal_brain_morphology | 0.80331137 |
| 140 | MP0000343_altered_response_to | 0.79803577 |
| 141 | MP0003075_altered_response_to | 0.79005045 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.78663799 |
| 143 | MP0001177_atelectasis | 0.77800457 |
| 144 | MP0002168_other_aberrant_phenotype | 0.77766892 |
| 145 | MP0000537_abnormal_urethra_morphology | 0.75975405 |
| 146 | MP0000249_abnormal_blood_vessel | 0.75242228 |
| 147 | MP0000383_abnormal_hair_follicle | 0.74980109 |
| 148 | MP0001664_abnormal_digestion | 0.74355370 |
| 149 | MP0002909_abnormal_adrenal_gland | 0.73901324 |
| 150 | MP0009840_abnormal_foam_cell | 0.73156743 |
| 151 | MP0002006_tumorigenesis | 0.73065882 |
| 152 | MP0005499_abnormal_olfactory_system | 0.72934161 |
| 153 | MP0005394_taste/olfaction_phenotype | 0.72934161 |
| 154 | MP0005257_abnormal_intraocular_pressure | 0.72638801 |
| 155 | MP0008775_abnormal_heart_ventricle | 0.72387464 |
| 156 | MP0000013_abnormal_adipose_tissue | 0.72076178 |
| 157 | MP0002090_abnormal_vision | 0.72069702 |
| 158 | MP0000579_abnormal_nail_morphology | 0.67003757 |
| 159 | MP0000372_irregular_coat_pigmentation | 0.65392713 |
| 160 | MP0008874_decreased_physiological_sensi | 0.64737440 |
| 161 | MP0002295_abnormal_pulmonary_circulatio | 0.64069355 |
| 162 | MP0004381_abnormal_hair_follicle | 0.59890686 |
| 163 | MP0000647_abnormal_sebaceous_gland | 0.59018236 |
| 164 | MP0000762_abnormal_tongue_morphology | 0.58540217 |
| 165 | MP0008872_abnormal_physiological_respon | 0.57892574 |
| 166 | MP0000751_myopathy | 0.57281458 |
| 167 | MP0003183_abnormal_peptide_metabolism | 0.55983556 |
| 168 | MP0000003_abnormal_adipose_tissue | 0.54099213 |
| 169 | MP0002796_impaired_skin_barrier | 0.53731210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.79056078 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.79056078 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.73942071 |
| 4 | Supranuclear gaze palsy (HP:0000605) | 5.08379670 |
| 5 | Myokymia (HP:0002411) | 5.03544119 |
| 6 | Abnormality of the corticospinal tract (HP:0002492) | 4.72430635 |
| 7 | Nemaline bodies (HP:0003798) | 4.53955748 |
| 8 | Peripheral hypomyelination (HP:0007182) | 4.41654658 |
| 9 | Insidious onset (HP:0003587) | 4.41436296 |
| 10 | Termporal pattern (HP:0011008) | 4.41436296 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 4.41022921 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 4.39169646 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.38559172 |
| 14 | Exercise-induced myalgia (HP:0003738) | 4.20072025 |
| 15 | Onion bulb formation (HP:0003383) | 4.01641450 |
| 16 | Ankle clonus (HP:0011448) | 3.91608980 |
| 17 | Action tremor (HP:0002345) | 3.70138143 |
| 18 | Focal motor seizures (HP:0011153) | 3.67336570 |
| 19 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.65128616 |
| 20 | Spastic gait (HP:0002064) | 3.64390483 |
| 21 | Parakeratosis (HP:0001036) | 3.59214606 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.48198451 |
| 23 | Increased mean platelet volume (HP:0011877) | 3.47162154 |
| 24 | Sensory axonal neuropathy (HP:0003390) | 3.44943215 |
| 25 | Pheochromocytoma (HP:0002666) | 3.38736852 |
| 26 | Menorrhagia (HP:0000132) | 3.34894073 |
| 27 | Dysmetria (HP:0001310) | 3.34470032 |
| 28 | Intention tremor (HP:0002080) | 3.34342055 |
| 29 | Ulnar claw (HP:0001178) | 3.31292559 |
| 30 | Retinal dysplasia (HP:0007973) | 3.18904439 |
| 31 | Onycholysis (HP:0001806) | 3.14700544 |
| 32 | Atonic seizures (HP:0010819) | 3.11814670 |
| 33 | Distal lower limb muscle weakness (HP:0009053) | 3.08867236 |
| 34 | Abnormal platelet volume (HP:0011876) | 3.07505819 |
| 35 | Scanning speech (HP:0002168) | 3.06839603 |
| 36 | Atrophic scars (HP:0001075) | 3.04307489 |
| 37 | Neuroendocrine neoplasm (HP:0100634) | 2.97643252 |
| 38 | Focal seizures (HP:0007359) | 2.97470036 |
| 39 | Slow saccadic eye movements (HP:0000514) | 2.97395842 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.92225701 |
| 41 | Abnormal auditory evoked potentials (HP:0006958) | 2.91810686 |
| 42 | Prolonged bleeding time (HP:0003010) | 2.90323518 |
| 43 | EMG: myopathic abnormalities (HP:0003458) | 2.89497826 |
| 44 | Distal lower limb amyotrophy (HP:0008944) | 2.85905255 |
| 45 | Exercise-induced muscle cramps (HP:0003710) | 2.84436932 |
| 46 | Cerebral hypomyelination (HP:0006808) | 2.83774437 |
| 47 | Increased connective tissue (HP:0009025) | 2.83504164 |
| 48 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.82980074 |
| 49 | Foot dorsiflexor weakness (HP:0009027) | 2.80928168 |
| 50 | Muscle fiber splitting (HP:0003555) | 2.79563631 |
| 51 | Bundle branch block (HP:0011710) | 2.79020953 |
| 52 | Abnormality of nail color (HP:0100643) | 2.77975725 |
| 53 | Akinesia (HP:0002304) | 2.75312620 |
| 54 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.75176859 |
| 55 | Urinary urgency (HP:0000012) | 2.74730172 |
| 56 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.69284037 |
| 57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.68905143 |
| 58 | Osteolytic defects of the hand bones (HP:0009699) | 2.66698071 |
| 59 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.66698071 |
| 60 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.65842939 |
| 61 | Milia (HP:0001056) | 2.63556692 |
| 62 | Cerebral hemorrhage (HP:0001342) | 2.60953251 |
| 63 | Hammertoe (HP:0001765) | 2.53989671 |
| 64 | Lower limb muscle weakness (HP:0007340) | 2.53592109 |
| 65 | Abnormality of the foot musculature (HP:0001436) | 2.47157533 |
| 66 | Decreased motor nerve conduction velocity (HP:0003431) | 2.45976790 |
| 67 | Neck muscle weakness (HP:0000467) | 2.45873546 |
| 68 | Megalencephaly (HP:0001355) | 2.43993111 |
| 69 | Limb dystonia (HP:0002451) | 2.39752464 |
| 70 | Alacrima (HP:0000522) | 2.38444027 |
| 71 | Plantar hyperkeratosis (HP:0007556) | 2.38234833 |
| 72 | Lower limb amyotrophy (HP:0007210) | 2.34317586 |
| 73 | Epileptic encephalopathy (HP:0200134) | 2.33150274 |
| 74 | Visual hallucinations (HP:0002367) | 2.33074468 |
| 75 | Progressive cerebellar ataxia (HP:0002073) | 2.31214404 |
| 76 | Dialeptic seizures (HP:0011146) | 2.30833353 |
| 77 | Absence seizures (HP:0002121) | 2.30678874 |
| 78 | Distal sensory impairment (HP:0002936) | 2.29482847 |
| 79 | Petechiae (HP:0000967) | 2.29370689 |
| 80 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.27884320 |
| 81 | Aplasia of the phalanges of the hand (HP:0009802) | 2.27884320 |
| 82 | Aplasia involving bones of the extremities (HP:0009825) | 2.27884320 |
| 83 | Autoamputation (HP:0001218) | 2.26563998 |
| 84 | Distal arthrogryposis (HP:0005684) | 2.24504939 |
| 85 | Rhabdomyolysis (HP:0003201) | 2.24452893 |
| 86 | Round ear (HP:0100830) | 2.23673603 |
| 87 | Premature rupture of membranes (HP:0001788) | 2.23473667 |
| 88 | Myoglobinuria (HP:0002913) | 2.23130898 |
| 89 | Axonal loss (HP:0003447) | 2.23115606 |
| 90 | Metabolic alkalosis (HP:0200114) | 2.22957644 |
| 91 | Truncal ataxia (HP:0002078) | 2.21725600 |
| 92 | Alopecia of scalp (HP:0002293) | 2.19708312 |
| 93 | Aortic aneurysm (HP:0004942) | 2.19688238 |
| 94 | Hypoplasia of the iris (HP:0007676) | 2.19093232 |
| 95 | Myopathic facies (HP:0002058) | 2.18576976 |
| 96 | Purpura (HP:0000979) | 2.18557476 |
| 97 | Difficulty running (HP:0009046) | 2.17895230 |
| 98 | Protrusio acetabuli (HP:0003179) | 2.16621114 |
| 99 | Popliteal pterygium (HP:0009756) | 2.15682736 |
| 100 | Increased circulating renin level (HP:0000848) | 2.14291706 |
| 101 | Arterial tortuosity (HP:0005116) | 2.13886996 |
| 102 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.13305679 |
| 103 | Generalized tonic-clonic seizures (HP:0002069) | 2.13159423 |
| 104 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 2.12200151 |
| 105 | Thickened helices (HP:0000391) | 2.11510033 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 2.10962304 |
| 107 | Steppage gait (HP:0003376) | 2.10411984 |
| 108 | Clumsiness (HP:0002312) | 2.08802189 |
| 109 | Stridor (HP:0010307) | 2.07413953 |
| 110 | Spastic tetraparesis (HP:0001285) | 2.06853111 |
| 111 | Clonus (HP:0002169) | 2.06184849 |
| 112 | Gingival bleeding (HP:0000225) | 2.04767911 |
| 113 | Progressive inability to walk (HP:0002505) | 2.04064192 |
| 114 | Hyporeflexia of lower limbs (HP:0002600) | 2.03475130 |
| 115 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.03005488 |
| 116 | Spinal rigidity (HP:0003306) | 2.02985459 |
| 117 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.00776294 |
| 118 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.99686521 |
| 119 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.99602734 |
| 120 | Epistaxis (HP:0000421) | 1.97947407 |
| 121 | Fragile skin (HP:0001030) | 1.97903698 |
| 122 | Anxiety (HP:0000739) | 1.97799107 |
| 123 | Leukodystrophy (HP:0002415) | 1.97418326 |
| 124 | Vascular tortuosity (HP:0004948) | 1.96361581 |
| 125 | Dysdiadochokinesis (HP:0002075) | 1.96303772 |
| 126 | Ventricular tachycardia (HP:0004756) | 1.96209349 |
| 127 | Impaired platelet aggregation (HP:0003540) | 1.95649771 |
| 128 | Abnormal platelet function (HP:0011869) | 1.95649771 |
| 129 | Humeroradial synostosis (HP:0003041) | 1.94404370 |
| 130 | Synostosis involving the elbow (HP:0003938) | 1.94404370 |
| 131 | Calf muscle hypertrophy (HP:0008981) | 1.94275861 |
| 132 | Abnormal eating behavior (HP:0100738) | 1.94004709 |
| 133 | Thick nail (HP:0001805) | 1.91916866 |
| 134 | Obstructive sleep apnea (HP:0002870) | 1.89065306 |
| 135 | Aortic dissection (HP:0002647) | 1.88752001 |
| 136 | Abnormality of the calf musculature (HP:0001430) | 1.87955824 |
| 137 | Febrile seizures (HP:0002373) | 1.87487712 |
| 138 | Abnormal atrioventricular conduction (HP:0005150) | 1.87136844 |
| 139 | Bulbar palsy (HP:0001283) | 1.87109571 |
| 140 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.86957780 |
| 141 | Mitral stenosis (HP:0001718) | 1.86674189 |
| 142 | CNS hypomyelination (HP:0003429) | 1.86401985 |
| 143 | Dysmetric saccades (HP:0000641) | 1.85068911 |
| 144 | Ankyloglossia (HP:0010296) | 1.85038233 |
| 145 | Mutism (HP:0002300) | 1.85031980 |
| 146 | Depression (HP:0000716) | 1.84888340 |
| 147 | Pili torti (HP:0003777) | 1.84818425 |
| 148 | Cerebral aneurysm (HP:0004944) | 1.83835548 |
| 149 | Rapidly progressive (HP:0003678) | 1.83646975 |
| 150 | Muscle stiffness (HP:0003552) | 1.83121279 |
| 151 | Split foot (HP:0001839) | 1.82800325 |
| 152 | Morphological abnormality of the inner ear (HP:0011390) | 1.82327687 |
| 153 | Postural instability (HP:0002172) | 1.81941900 |
| 154 | Hypomagnesemia (HP:0002917) | 1.81245648 |
| 155 | Sudden death (HP:0001699) | 1.80505813 |
| 156 | Hyperphosphatemia (HP:0002905) | 1.79997677 |
| 157 | Abnormality of saccadic eye movements (HP:0000570) | 1.79720220 |
| 158 | Palmoplantar hyperkeratosis (HP:0000972) | 1.79005577 |
| 159 | Fragile nails (HP:0001808) | 1.78028808 |
| 160 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.77364345 |
| 161 | Subaortic stenosis (HP:0001682) | 1.77364345 |
| 162 | Peripheral demyelination (HP:0011096) | 1.76682396 |
| 163 | Wormian bones (HP:0002645) | 1.76144975 |
| 164 | Advanced eruption of teeth (HP:0006288) | 1.75857923 |
| 165 | Decreased lacrimation (HP:0000633) | 1.75641223 |
| 166 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.75437096 |
| 167 | Cardiovascular calcification (HP:0011915) | 1.75011279 |
| 168 | Hypokalemic alkalosis (HP:0001949) | 1.74492975 |
| 169 | Urinary incontinence (HP:0000020) | 1.74164005 |
| 170 | Asymmetric septal hypertrophy (HP:0001670) | 1.73890400 |
| 171 | Diaphragmatic weakness (HP:0009113) | 1.73742215 |
| 172 | Nail dystrophy (HP:0008404) | 1.73414904 |
| 173 | Ridged nail (HP:0001807) | 1.72872461 |
| 174 | Type II lissencephaly (HP:0007260) | 1.72459724 |
| 175 | Psychosis (HP:0000709) | 1.72087513 |
| 176 | Generalized myoclonic seizures (HP:0002123) | 1.71842000 |
| 177 | Rigidity (HP:0002063) | 1.71798421 |
| 178 | Paralysis (HP:0003470) | 1.71430907 |
| 179 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.70783428 |
| 180 | Torticollis (HP:0000473) | 1.70737975 |
| 181 | Poor speech (HP:0002465) | 1.70688746 |
| 182 | Anteriorly placed anus (HP:0001545) | 1.70326210 |
| 183 | Scapular winging (HP:0003691) | 1.69771636 |
| 184 | Overgrowth (HP:0001548) | 1.68864948 |
| 185 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65853896 |
| 186 | Abnormal blistering of the skin (HP:0008066) | 1.64026238 |
| 187 | Insomnia (HP:0100785) | 1.63919354 |
| 188 | Abnormality of the Achilles tendon (HP:0005109) | 1.61801144 |
| 189 | Heart block (HP:0012722) | 1.61625373 |
| 190 | Back pain (HP:0003418) | 1.61542031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.37947802 |
| 2 | OXSR1 | 3.50349390 |
| 3 | OBSCN | 2.90759696 |
| 4 | MAPKAPK5 | 2.63380693 |
| 5 | WNK1 | 2.50768255 |
| 6 | EPHB1 | 2.47904840 |
| 7 | NTRK1 | 2.47887255 |
| 8 | TTN | 2.42458007 |
| 9 | WNK4 | 2.41551973 |
| 10 | RIPK1 | 2.37691055 |
| 11 | LIMK1 | 2.34158209 |
| 12 | EPHA2 | 2.18029907 |
| 13 | MYLK | 2.15589519 |
| 14 | EEF2K | 2.08222766 |
| 15 | MAP3K9 | 2.07462641 |
| 16 | CDK19 | 2.00375234 |
| 17 | KSR2 | 1.98998915 |
| 18 | NTRK3 | 1.98704330 |
| 19 | BCR | 1.90572901 |
| 20 | MAPKAPK3 | 1.88583597 |
| 21 | AKT3 | 1.85608040 |
| 22 | PKN1 | 1.80933420 |
| 23 | PAK6 | 1.76920330 |
| 24 | EIF2AK1 | 1.72388079 |
| 25 | MAP3K3 | 1.70118020 |
| 26 | MET | 1.69536644 |
| 27 | UHMK1 | 1.66597910 |
| 28 | TRIB3 | 1.64371512 |
| 29 | MINK1 | 1.64149999 |
| 30 | PBK | 1.57657446 |
| 31 | LATS2 | 1.56438376 |
| 32 | MAP3K2 | 1.55967532 |
| 33 | MST4 | 1.49255487 |
| 34 | MARK1 | 1.48801998 |
| 35 | ROCK2 | 1.45405544 |
| 36 | NEK9 | 1.45254287 |
| 37 | CAMK2B | 1.44272937 |
| 38 | BMX | 1.43916607 |
| 39 | PDGFRA | 1.42655070 |
| 40 | ARAF | 1.42024541 |
| 41 | LMTK2 | 1.41457797 |
| 42 | SGK223 | 1.39106642 |
| 43 | SGK494 | 1.39106642 |
| 44 | BMPR2 | 1.37266857 |
| 45 | FGFR2 | 1.37181515 |
| 46 | PNCK | 1.36830517 |
| 47 | EPHA4 | 1.34113214 |
| 48 | PAK3 | 1.33412630 |
| 49 | PTK2 | 1.32104331 |
| 50 | PHKG2 | 1.31741877 |
| 51 | PHKG1 | 1.31741877 |
| 52 | TNIK | 1.29700452 |
| 53 | CAMK2D | 1.27707337 |
| 54 | CDK5 | 1.25459890 |
| 55 | SCYL2 | 1.24861052 |
| 56 | CSNK1G3 | 1.23643981 |
| 57 | CSNK1G2 | 1.22585715 |
| 58 | MAP3K4 | 1.20739044 |
| 59 | CASK | 1.20032948 |
| 60 | MAPK12 | 1.19966501 |
| 61 | SIK1 | 1.17555761 |
| 62 | TESK1 | 1.17380543 |
| 63 | CAMK2G | 1.14474955 |
| 64 | CSNK1A1L | 1.12980990 |
| 65 | PIK3CG | 1.07665243 |
| 66 | NEK6 | 1.04653331 |
| 67 | ILK | 1.03936436 |
| 68 | CDK14 | 1.03198879 |
| 69 | FGR | 1.01565536 |
| 70 | SGK3 | 1.01136871 |
| 71 | STK38 | 0.98799024 |
| 72 | MOS | 0.94889005 |
| 73 | CAMK2A | 0.93488105 |
| 74 | PIM2 | 0.90884520 |
| 75 | CDK15 | 0.90822165 |
| 76 | GRK5 | 0.90090934 |
| 77 | PRPF4B | 0.89448601 |
| 78 | ERN1 | 0.88230459 |
| 79 | MAP2K7 | 0.87779577 |
| 80 | CDK18 | 0.87272022 |
| 81 | PRKD3 | 0.85398761 |
| 82 | PRKCH | 0.85061351 |
| 83 | STK24 | 0.84784867 |
| 84 | TAOK2 | 0.84526381 |
| 85 | PTK2B | 0.84442956 |
| 86 | MAPK13 | 0.83720380 |
| 87 | CSNK1G1 | 0.82455813 |
| 88 | MAP3K13 | 0.81838617 |
| 89 | MAP2K2 | 0.80807511 |
| 90 | PDPK1 | 0.79689813 |
| 91 | NTRK2 | 0.79048408 |
| 92 | PDGFRB | 0.78957228 |
| 93 | SGK2 | 0.78157289 |
| 94 | JAK1 | 0.78148417 |
| 95 | CDK11A | 0.77936031 |
| 96 | PAK4 | 0.77562713 |
| 97 | CAMK1G | 0.76724241 |
| 98 | PRKCE | 0.76662252 |
| 99 | PAK2 | 0.76560483 |
| 100 | TYRO3 | 0.76175044 |
| 101 | RET | 0.73910921 |
| 102 | PRKD1 | 0.73835314 |
| 103 | MAP2K3 | 0.72952078 |
| 104 | MARK2 | 0.72489814 |
| 105 | MAP3K12 | 0.70138900 |
| 106 | DAPK3 | 0.69135674 |
| 107 | PRKD2 | 0.68057919 |
| 108 | DAPK2 | 0.67558245 |
| 109 | MAP3K1 | 0.65534633 |
| 110 | PRKCQ | 0.65182800 |
| 111 | MST1R | 0.64024380 |
| 112 | STK11 | 0.62330964 |
| 113 | CLK1 | 0.61801431 |
| 114 | TESK2 | 0.61722876 |
| 115 | RAF1 | 0.61582786 |
| 116 | SMG1 | 0.61549959 |
| 117 | LATS1 | 0.60283771 |
| 118 | FYN | 0.59959529 |
| 119 | MAPK15 | 0.59008543 |
| 120 | EPHB2 | 0.58471586 |
| 121 | FER | 0.58005725 |
| 122 | MAP2K4 | 0.57536188 |
| 123 | IRAK3 | 0.56932776 |
| 124 | ICK | 0.56873509 |
| 125 | MAP2K1 | 0.56320915 |
| 126 | PIK3CA | 0.55879934 |
| 127 | MUSK | 0.55640917 |
| 128 | FES | 0.54715240 |
| 129 | TRPM7 | 0.53931999 |
| 130 | GRK7 | 0.53759786 |
| 131 | TNK2 | 0.52197401 |
| 132 | CAMK1D | 0.52158905 |
| 133 | DMPK | 0.48722446 |
| 134 | PDK1 | 0.48505044 |
| 135 | CAMKK2 | 0.48017269 |
| 136 | TAOK1 | 0.46650048 |
| 137 | PRKCG | 0.46470275 |
| 138 | CAMKK1 | 0.45860634 |
| 139 | CSNK1A1 | 0.45809845 |
| 140 | AKT2 | 0.44758868 |
| 141 | MTOR | 0.43380876 |
| 142 | PLK2 | 0.42821417 |
| 143 | BRAF | 0.41945745 |
| 144 | TGFBR2 | 0.41556617 |
| 145 | RIPK4 | 0.41472335 |
| 146 | ROCK1 | 0.41004135 |
| 147 | EPHA3 | 0.40991700 |
| 148 | ZAP70 | 0.40832372 |
| 149 | PRKAA2 | 0.39983403 |
| 150 | KSR1 | 0.39763936 |
| 151 | HIPK2 | 0.39592873 |
| 152 | PRKG1 | 0.39581469 |
| 153 | BMPR1B | 0.36872759 |
| 154 | DYRK2 | 0.36726183 |
| 155 | PRKACB | 0.36597779 |
| 156 | DDR2 | 0.34558757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.18811544 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.53007532 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.34256190 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.33342380 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.25854126 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.07505987 |
| 7 | Platelet activation_Homo sapiens_hsa04611 | 1.96551525 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.95097713 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.93396216 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.90995206 |
| 11 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.86467912 |
| 12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.79061567 |
| 13 | Focal adhesion_Homo sapiens_hsa04510 | 1.77596278 |
| 14 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.74392092 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.74049969 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72346653 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.70376009 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69433790 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.66229789 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64434742 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.62510814 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61992783 |
| 23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.59853764 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.59127681 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55230002 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.53011790 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51612975 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.49517373 |
| 29 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.48409254 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.44410562 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39550883 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.38404281 |
| 33 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.34986642 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.34639248 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.33315865 |
| 36 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30757959 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.24917926 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.24096094 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.22132004 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.21673322 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.21015602 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.20865369 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19875178 |
| 44 | Amoebiasis_Homo sapiens_hsa05146 | 1.18162026 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17934483 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17713195 |
| 47 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.16812365 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.15860236 |
| 49 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14590673 |
| 50 | Insulin secretion_Homo sapiens_hsa04911 | 1.12314821 |
| 51 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12041987 |
| 52 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11440809 |
| 53 | Renin secretion_Homo sapiens_hsa04924 | 1.11431392 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08746013 |
| 55 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08007951 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07389629 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 1.07300042 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05558496 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05469038 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.05221270 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05063447 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.04167884 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.03915149 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 1.03841644 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03435414 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.02638240 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01827286 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.01210240 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00426110 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98973928 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98674025 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98673552 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97524356 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97258624 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96828066 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96233243 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94148542 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.93952240 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91670413 |
| 80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88935456 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88786070 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88734629 |
| 83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88495227 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.88134402 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87061722 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86462830 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.86027074 |
| 88 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.85942911 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85239919 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84780433 |
| 91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84217777 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.82963726 |
| 93 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80347317 |
| 94 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79782411 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79656623 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77839659 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77751953 |
| 98 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77476847 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75630199 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74731511 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.73957708 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.73091188 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.72994089 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.71810133 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71640308 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.71172847 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.71141701 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71105755 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70400573 |
| 110 | Phagosome_Homo sapiens_hsa04145 | 0.69078962 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66994681 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65824483 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65587674 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65555483 |
| 115 | Melanogenesis_Homo sapiens_hsa04916 | 0.65253901 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61184528 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60146422 |
| 118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59745699 |
| 119 | Salmonella infection_Homo sapiens_hsa05132 | 0.59087113 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57222389 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56496294 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.54724753 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.54575477 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54384033 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.54059247 |
| 126 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53864627 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53850264 |
| 128 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53307057 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52846163 |
| 130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52076956 |
| 131 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51974173 |
| 132 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51684929 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.51263430 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50398885 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50297681 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.50094993 |
| 137 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49813167 |
| 138 | Shigellosis_Homo sapiens_hsa05131 | 0.48659685 |
| 139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47428937 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45315322 |
| 141 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45198538 |
| 142 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44691791 |
| 143 | Protein export_Homo sapiens_hsa03060 | 0.43880412 |
| 144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43431826 |
| 145 | Bile secretion_Homo sapiens_hsa04976 | 0.43315634 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.42505519 |
| 147 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.41700460 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41549611 |
| 149 | Prion diseases_Homo sapiens_hsa05020 | 0.41142868 |
| 150 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40924645 |

